| Sigma Healthcare Limited (SIG) ORDINARY FULLY PAID |
Health Care |
$33,708 |
Sigma Half Year Results Presentation
|
26 Feb 2026 8:24AM |
$2.990 |
$2.920 |
fallen by
2.34%
|
|
SIG - Price-sensitive ASX Announcement
Full Release
Key Points
- Sigma Healthcare reported a 14.9% increase in revenue for 1H26, reaching $5.5 billion.
- The company achieved a Normalised EBIT of $582.9 million, an 18.7% increase from the previous period.
- Normalised NPAT rose by 19.2% to $392.0 million.
- Sigma's Gross Profit Margin was stable at 18.3%, driven by favorable mix and supplier support.
- Operating expenses increased by 9.8%, with a focus on supporting domestic and international growth.
- Sigma opened 12 new international stores, bringing the total to 97, with international sales up 24.5%.
- The integration and synergy programs are on track with $13 million synergies realized so far.
- Domestic like-for-like sales in Chemist Warehouse branded stores increased by 15.0%.
- Sigma continues to expand its portfolio of owned and exclusive label products, contributing to revenue growth.
- The company's strategic priorities include expanding their pharmacy franchise and enhancing product differentiation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IDP Education Limited (IEL) ORDINARY FULLY PAID |
Consumer Discretionary |
$807 |
H1 FY 26 Results Announcement
|
26 Feb 2026 8:24AM |
$4.590 |
$2.900 |
fallen by
36.82%
|
|
IEL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for H1 FY26 was $462.2 million, a 6% decrease.
- Student Placement yield increased by 15%, Language Testing by 8%.
- Volumes declined for Student Placement by 25% and Language Testing by 7%.
- Adjusted EBIT was $87.5 million, a 14% decline.
- Transformation program aims for a $25 million cost base reduction in FY26.
- FY26 EBIT guidance upgraded to $120-$130 million.
- Interim dividend of 3.0 cents per share declared.
- Focus on digital and AI tools for efficiency and growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ReadyTech Holdings Limited (RDY) ORDINARY FULLY PAID |
Information Technology |
$165 |
Appendix 4D and Interim Report
|
26 Feb 2026 8:24AM |
$1.730 |
$1.335 |
fallen by
22.83%
|
|
RDY - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from ordinary activities increased by 5.6% to $61.6 million.
- Loss after tax was reduced to $1.35 million, a 92.8% improvement from the previous period.
- No dividends were paid or declared during the period.
- Significant investment in research and development, comprising 29.5% of revenue.
- Challenges included market conditions, managed payroll churn, and a VETtrak cyber incident.
- The company is organised into Education and Work Pathways, Workforce Solutions, and Government and Justice segments.
- Deficiency in net current assets due to contract liabilities and employee benefits.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ramsay Health Care Limited (RHC) ORDINARY FULLY PAID |
Health Care |
$8,626 |
2026 Half Year Results Presentation
|
26 Feb 2026 8:24AM |
$38.170 |
$37.370 |
fallen by
2.10%
|
|
RHC - Price-sensitive ASX Announcement
Full Release
Key Points
- Ramsay Health Care Limited reported a 7.3% increase in Group underlying EBIT for the first half of the 2026 financial year.
- The Group's revenue grew by 9.7% compared to the first half of FY25, totaling $9.3 billion.
- Australian operations saw a 7.1% increase in EBIT, driven by increased activity and higher revenue indexation.
- Ramsay Santé's performance showed improvement with a 14.2% rise in underlying EBIT.
- The Group completed significant developments, including the Joondalup Private Hospital expansion.
- The Funding Group maintained a leverage ratio of 2.22x, within its target range.
- Capital expenditure for FY26 is expected to be between $755-795 million, focusing on procedural capacity in Australia.
- Ramsay UK faced challenges due to NHS budget constraints, but the company expects to benefit from additional future funding.
- Elysium's turnaround is progressing with cost reduction and site optimization efforts underway.
- Net financing expenses are forecasted to be $590-610 million for the fiscal year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IDP Education Limited (IEL) ORDINARY FULLY PAID |
Consumer Discretionary |
$807 |
H1 FY26 Interim Financial Report
|
26 Feb 2026 8:24AM |
$4.590 |
$2.900 |
fallen by
36.82%
|
|
IEL - Price-sensitive ASX Announcement
Full Release
Key Points
- H1 FY26 revenue fell by 5% to $462.2 million.
- Student placement revenue declined by 10%.
- Asia's revenue decreased by 12% due to lower volumes in Canada, US, and UK.
- Australasia experienced an 8% increase in revenue.
- Rest of World's revenue grew by 11%.
- Adjusted NPAT declined by 25% to $48.6 million.
- The company implemented a new accounting policy for revenue recognition.
- Corporate costs increased by 51% due to transformation initiatives.
- IDP maintained a consistent cash conversion rate of 59%.
- The transformation program aims for a more agile, technology-enabled organization.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sigma Healthcare Limited (SIG) ORDINARY FULLY PAID |
Health Care |
$33,708 |
Half Year Accounts
|
26 Feb 2026 8:23AM |
$2.990 |
$2.920 |
fallen by
2.34%
|
|
SIG - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for the half year was $5.5 billion with a significant increase from the previous year's $1.96 billion.
- Gross profit stood at $1,007.8 million, showing a substantial increase.
- Net profit after tax attributable to owners was $379.8 million, marking over 22% growth from the previous period.
- Basic and diluted earnings per share rose to 3.3 cents from 3.1 cents.
- The company declared an interim dividend of 2.0 cents per share, fully franked.
- Total equity of the group increased to $4.89 billion, up from $4.66 billion.
- The company operates in multiple regions including Australia, New Zealand, China, Ireland, and UAE.
- Total liabilities amounted to $3.85 billion, slightly up from $3.63 billion.
- The financial report confirms no contraventions of the Corporations Act 2001 or professional conduct codes.
- A merger with Chemist Warehouse was completed, incurring non-recurring costs for integration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ramsay Health Care Limited (RHC) ORDINARY FULLY PAID |
Health Care |
$8,626 |
2026 Half Year Results Announcement
|
26 Feb 2026 8:23AM |
$38.170 |
$37.370 |
fallen by
2.10%
|
|
RHC - Price-sensitive ASX Announcement
Full Release
Key Points
- Ramsay reported a 253.2% increase in net profit after tax compared to the prior period.
- Underlying EBIT grew by 7.3%, and underlying NPAT increased by 8.1%.
- Strong performance in Australian operations with ongoing strategic transformation.
- Proposed acquisition of National Capital Private Hospital to expand in Canberra.
- Focus on high acuity cases and operational excellence in the UK amid NHS constraints.
- Mitigation measures implemented to address European funding headwinds.
- Declared a fully franked interim dividend of 42.5 cents per share.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Native Mineral Resources Holdings Limited (NMR) ORDINARY FULLY PAID |
Materials |
$54 |
NMR hits 14m @ 8.21g/t Au from 15m at Podosky, QLD
|
26 Feb 2026 8:23AM |
$0.090 |
$0.049 |
fallen by
45.56%
|
|
NMR - Price-sensitive ASX Announcement
Full Release
Key Points
- NMR completed 11 out of 21 planned drill holes at Podosky.
- Significant gold intercept of 14m at 8.21g/t Au from 15m.
- Drilling confirms historic results and supports resource confidence.
- Joint venture with Haoma Mining to process ore at Blackjack.
- Proceeds from ore processing split 50-50 between NMR and Haoma.
- Program aims to convert Podosky resource into a mine-ready plan.
- Further drilling and exploration to expand resource definition.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pro Medicus Limited (PME) ORDINARY FULLY PAID |
Health Care |
$14,237 |
Change of Director's Interest Notice - Anthony Hall
|
26 Feb 2026 8:23AM |
$116.230 |
$136.280 |
risen by
17.25%
|
|
| MAAS Group Holdings Limited (MGH) ORDINARY FULLY PAID |
Industrials |
$1,590 |
Update - Notification of buy-back - MGH
|
26 Feb 2026 8:23AM |
$4.290 |
$4.400 |
risen by
2.56%
|
|
| Nova Eye Medical Limited (EYE) ORDINARY FULLY PAID |
Health Care |
$37 |
Investor Webinar Tuesday 3 March @11.30 AEDT
|
26 Feb 2026 8:23AM |
$0.160 |
$0.130 |
fallen by
18.75%
|
|
| Ramsay Health Care Limited (RHC) ORDINARY FULLY PAID |
Health Care |
$8,626 |
2026 Half Year Financial Report
|
26 Feb 2026 8:23AM |
$38.170 |
$37.370 |
fallen by
2.10%
|
|
RHC - Price-sensitive ASX Announcement
Full Release
Key Points
- Net profit after tax for the period was A$139.7 million.
- Revenue in Australia increased by 7.9%.
- European segment revenue rose by 11.5%.
- Total comprehensive income was A$122.4 million.
- Underlying EBIT and EBITDA increased across most regions.
- Ongoing performance improvement plans are expected to continue gaining traction.
- Focus on negotiating payor indexation in the UK for financial year 2026/27.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Control Bionics Limited (CBL) ORDINARY FULLY PAID |
Health Care |
$27 |
Half Yearly Report and Accounts
|
26 Feb 2026 8:23AM |
$0.060 |
$0.065 |
risen by
8.33%
|
|
CBL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues from ordinary activities decreased by 26% to $2,820,044.
- Loss from ordinary activities after tax increased by 1201% to $3,609,172.
- No dividends were paid, recommended, or declared during the half-year.
- Net tangible assets per ordinary security were 0.73 cents as of 31 December 2025.
- Control Bionics Limited gained control over Neuro Elite Athletics, LLC, increasing its ownership to 100%.
- The financial statements were reviewed by auditors, with no contraventions of the auditor independence requirements of the Corporations Act 2001.
- Material uncertainty regarding going concern was noted, but the review conclusion was not modified.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cleanaway Waste Management Limited (CWY) ORDINARY FULLY PAID |
Industrials |
$4,931 |
Half Year Results ASX & Media Release and Presentation
|
26 Feb 2026 8:23AM |
$2.400 |
$2.200 |
fallen by
8.33%
|
|
CWY - Price-sensitive ASX Announcement
Full Release
Key Points
- Cleanaway Waste Management reported a 13.0% increase in net revenue to $1,875.3 million for the half-year ending FY26.
- Underlying EBIT rose by 16.9% to $228.2 million, with an EBIT margin improvement of 40 basis points to 12.2%.
- The company's underlying NPAT increased by 17.8% to $109.7 million.
- Free Cash Flow decreased by 21.5% to $74.2 million due to acquisition and restructuring costs.
- A dividend of 3.35 cents per share was declared, up 19.6% from the previous year.
- EPSA rose by 18.2% to 5.2 cents, while underlying ROCE increased by 80 basis points to 9.4%.
- CWY's FY26 EBIT guidance was upgraded to between $480 million and $500 million.
- The company experienced strong results from acquisitions, with Contract Resources outperforming expectations.
- Positive outlook for solid waste services and environmental & technical solutions was noted.
- Capital expenditure for FY26 is expected to be approximately $415 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cleanaway Waste Management Limited (CWY) ORDINARY FULLY PAID |
Industrials |
$4,931 |
Dividend/Distribution - CWY
|
26 Feb 2026 8:22AM |
$2.400 |
$2.200 |
fallen by
8.33%
|
|
| Cleanaway Waste Management Limited (CWY) ORDINARY FULLY PAID |
Industrials |
$4,931 |
Appendix 4D and Consolidated Financial Report
|
26 Feb 2026 8:22AM |
$2.400 |
$2.200 |
fallen by
8.33%
|
|
CWY - Price-sensitive ASX Announcement
Full Release
Key Points
- Cleanaway Waste Management Limited's half-year financial report reviewed
- Period ending 31 December 2025
- Includes Consolidated Balance Sheet and Statements of Comprehensive Income, Changes in Equity, and Cash Flows
- Report complies with Corporations Act 2001 and AASB 134
- No contraventions of auditor independence or professional conduct codes
- Directors responsible for report preparation
- Review conducted by Ernst & Young
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Credit Clear Limited (CCR) ORDINARY FULLY PAID |
Information Technology |
$114 |
1HFY26 Results Presentation
|
26 Feb 2026 8:22AM |
$0.235 |
$0.218 |
fallen by
7.45%
|
|
| Smartgroup Corporation Ltd (SIQ) ORDINARY FULLY PAID |
Industrials |
$1,353 |
Appendix 4G and Corporate Governance Statement
|
26 Feb 2026 8:22AM |
$8.300 |
$9.850 |
risen by
18.67%
|
|
| Credit Clear Limited (CCR) ORDINARY FULLY PAID |
Information Technology |
$114 |
HY Results - Digital collections aid earnings improvement
|
26 Feb 2026 8:22AM |
$0.235 |
$0.218 |
fallen by
7.45%
|
|
| Capral Limited (CAA) ORDINARY FULLY PAID |
Materials |
$193 |
Dividend/Distribution - CAA
|
26 Feb 2026 8:22AM |
$12.270 |
$12.050 |
fallen by
1.79%
|
|
| Capral Limited (CAA) ORDINARY FULLY PAID |
Materials |
$193 |
Capral Important Dates
|
26 Feb 2026 8:22AM |
$12.270 |
$12.050 |
fallen by
1.79%
|
|
| Capral Limited (CAA) ORDINARY FULLY PAID |
Materials |
$193 |
Capral Full Year 2025 Results Presentation
|
26 Feb 2026 8:21AM |
$12.270 |
$12.050 |
fallen by
1.79%
|
|
CAA - Price-sensitive ASX Announcement
Full Release
Key Points
- Capral Limited reported a 4% decline in sales volume while revenue increased by 6% in 2025.
- Despite lower sales volumes, Capral's underlying EBITDA grew by 2% to $59.6 million.
- The company achieved a net profit after tax of $35.6 million for the financial year 2025.
- Capral's strategy focuses on building on current strengths, optimizing operations, and growing for the future.
- Capital allocation remains disciplined, prioritizing a strong balance sheet and growth opportunities.
- The aluminium market has faced higher and volatile metal costs.
- Capral aims to increase its presence in architectural markets and expand its distribution footprint.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Credit Clear Limited (CCR) ORDINARY FULLY PAID |
Information Technology |
$114 |
Half Yearly Report and Accounts
|
26 Feb 2026 8:21AM |
$0.235 |
$0.218 |
fallen by
7.45%
|
|
CCR - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased to AUD 25,020,000 for HY 2025.
- Net loss after tax improved to AUD 795,000 from AUD 2,174,000.
- Capital raise of AUD 12.75 million through share issuance.
- No dividends were paid, proposed, or declared.
- Principal activities included debt resolution services and digital platform development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Autosports Group Limited (ASG) ORDINARY FULLY PAID |
Consumer Discretionary |
$499 |
Autosports Group to acquire Solitaire Automotive Group
|
26 Feb 2026 8:21AM |
$3.130 |
$2.340 |
fallen by
25.24%
|
|
ASG - Price-sensitive ASX Announcement
Full Release
Key Points
- Autosports Group to acquire Solitaire Automotive Group.
- Acquisition valued at approximately $50 million.
- Solitaire Automotive generates about $300 million in revenue.
- Acquisition marks entry into South Australian market.
- Deal includes cash and ASG shares as consideration.
- Completion expected by April 2026, subject to approvals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pantoro Gold Limited (PNR) ORDINARY FULLY PAID |
Materials |
$1,239 |
Change in substantial holding
|
26 Feb 2026 8:21AM |
$5.690 |
$3.160 |
fallen by
44.46%
|
|
Call 1300 880 160
Start a chat
Schedule a call
